sábado, 23 de enero de 2016

Translational Medicine Communications is now accepting submissions

Translational Medicine Communications
Editor-in-Chief: Francesco Marincola (Qatar)
Submit a ManuscriptEditorial BoardAuthor InstructionsArticle Alerts
I am pleased to announce that submissions are now open for the brand new open accessjournal, Translational Medicine Communications.
Translational Medicine Communications is led by Editor-in-Chief Francesco Marincola of Sidra Medical and Research Center, and supported by an esteemed Editorial Board. It is the companion journal to Journal of Translational Medicine.
About the journal
Translational Medicine Communications aims to publish open access research, as well as review, methodology and protocol articles that facilitate the communication between basic and clinical science.
The journal covers all areas of translational medicine but also has several special sections:
-Cancer microenvironment - Edited by Fernando Vidal-Vanaclocha
-Cardiovascular, Metabolic and Lipoprotein Translation - Edited by Nehal N. Mehta
-Cell, tissue and gene therapy - Edited by David Stroncek
-Clinical translation - Edited by Lana Kandalaft
-Combination strategies - Edited by Paolo A. Ascierto
-Computational modeling and epidemiology - Edited by Michael Liebman and Sabrina Molinaro
-Disease biomarkers - Edited by Xiangdong Wang
-Immunobiology and immunotherapy - Edited by Adrian Bot
-Immunovirology - Edited by Luigi Buonaguro
-Medical Bioinformatics - Edited by Samir K. Brahmachari
-Neuroscience - Edited by Luis F. Alguacil
-Nutrition & metabolism - Edited by Laura Soldati
-Pain, Critical Care and Anesthesia - Edited by Yasin S. Al Makadma
-Patient-targeted molecular therapies - Edited by Francesco Chiappelli and Francesco Piva
-Personalised medicine - Edited by Lotfi Chouchane
-Translational Imaging - Edited by Ravinder Reddy

About the Editor-in-Chief
Dr. Francesco M. MarincolaDr. Francesco M. Marincola, MD, FACS, is the inaugural Chief Research Officer of Sidra Medical and Research Center, a unique hospital and research center in Doha, Qatar. Dr. Marincola joined Sidra from the U.S. National Institutes of Health (NIH), where he held the positions of Chief of the Infectious Disease and Immunogenetics Section (IDIS) and Tenured Senior Investigator. He was also Director or the Immunogenetics Program, Department of Transfusion Medicine, Director of the Federation of Clinical Immunology Societies (FOCIS) Center for Excellence and Co-Director of the Trans-NIH Center for Human Immunology.
He is President of the Society for the Immunotherapy of Cancer and President of the International Society for Translational Medicine. Dr. Marincola received his MD summa cum laude from the University of Milan and his surgery training from Stanford University.Find Dr. Marincola’s Publications In PubMed

Reasons to publish with us
-Expert Editorial Board
-High quality peer review service
-Rapid publication upon acceptance
-Highest possible global visibility for your research
Keep up to date – register to get the latest articles delivered straight to your inbox.
Sincerely yours
Todd Hummel
Editorial Director, BioMed Central

BioMed Central
BioMed Central Ltd, 236 Gray's Inn Road, London, WC1X 8HB, United Kingdom.
Part of Springer Science+Business Media. Privacy Policy.

No hay comentarios: